Tenon Medical prices $2.85 million PIPE financing at $1.285 per share

Tenon Medical Inc. (NASDAQ: TNON) announced the pricing of a private investment in public equity financing that will raise $2.85 million in gross proceeds from accredited investors.

Under securities purchase agreements dated September 10, 2025, the medical device company will issue 2,217,904 shares of common stock and warrants to purchase an additional 2,217,904 shares at a combined offering price of $1.285 per share and warrant. The warrants carry a strike price of $1.16 per share and expire three years from issuance.

The financing includes participation from strategic industry partners and members of Tenon's management team. The closing remains subject to customary conditions for transactions of this type.

Tenon plans to use proceeds for working capital and general corporate purposes, including upcoming product launches, expansion of commercial operations, advancement of clinical studies, and continued investment in core business operations.

The securities have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.

Based in Los Gatos, California, Tenon Medical develops medical devices for sacro-pelvic disorders. The company's Catamaran SI Joint Fusion System launched nationally in October 2022 and uses a single titanium implant for sacroiliac joint procedures.

You May Also Be Interested In

• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Sigma Lithium resumes full operations after signing TAC agreement